Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer

Print

Tarceva works by inhibiting receptor tyrosine kinase activity, the protein product of the EGFR gene. (Source: ABPI)
 
«Back | Next»




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development